Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...
Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for ...
Researchers at the University of Toronto's Institute of Biomedical Engineering have found that studying blood flow in leg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback